- Poster presentation
- Open Access
Left atrial late gadolinium enhancement following external beam radiation for lymphoma: a potential model for exploring radiation-related heart disease
© Harrison et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
We are able to detect subclinical post-irradiation changes to the heart with left atrial late gadolinium enhanced magnetic resonance imaging (LGE-MRI).
There are over 11 million cancer survivors, yet many long-term cancer survivors experience lasting changes including cardiac functional and anatomical abnormalities following external beam radiation and chemotherapy. One of the well-established pathological and histological sequelae of radiation exposure to the heart is intense post-irradiation injury with fibrotic changes. Here, we have explored the ability to apply LGE to identify the extent of left atrial uptake after radiation therapy.
A total of 20 patients were enrolled in this study; 10 patients (ages 29 to 64 years) who had survived 9.2 ± 25 years after thoracic external beam radiation for lymphoma and 10 control patients (ages 55 to 66 years) recruited from the University colonoscopy center. All patients underwent a MRI study including cine imaging, left ventricular LGE, and high-resolution LGE imaging of the left atrium. The extent of late gadolinium enhancement was calculated as a relative percent of total left atrial wall using a threshold-based algorithm based on pixel intensity distribution.
Patients with thoracic radiation for lymphoma have greater LGE reflecting radiation-induced injury than in an older group of controls without thoracic radiation therapy. LGE-MRI shows promise for finding and screening for prevalent myocardial tissue changes in this group of patients. Further studies with larger patient populations post thoracic radiation therapy with and without chemotherapy (as chemotoxic effects also include fibrotic changes) and with longitudinal follow up would be useful for correlation with external beam radiation dosimetry and the development of future cardiovascular events in long-term cancer survivors.
University of Utah Seed Grant.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.